Revolutionizing Radiology with Tokenized and De-Identified Imaging Data
Radiology, or diagnostic imaging, consists of procedures that take and process images of different parts of the body. Radiology, in its various processes, offers the means to visualize internal organs. Imaging modalities employed in healthcare include X-rays, MRIs, ultrasounds, CT scans, mammography, nuclear medicine, fluoroscopy, bone mineral densitometry, and PET scans.
Radiology plays an important role in the management of diseases, as it provides a variety of methods for the detection, staging, treatment planning, and monitoring of diseases. Radiology helps in the early detection of cancer, neurodegenerative, and cardiovascular diseases. And early detection further gives way to planning for early intervention and better outcomes. Imaging is also critical for planning surgery, radiation therapy, and other treatments since it gives accurate images of the targeted area.Additionally, radiology enables the monitoring of patients' health and journey.
Monitoring the course or remission of diseases and determining the effectiveness of treatment, e.g., tumor regression in cancer treatment, has become possible because of imaging. Also, radiological results supply information for research studies, which aids in examining the efficacy of treatments and comparative studies. Imaging also aids in comprehending the natural history of disease, and formulating new diagnostic and therapeutic approaches.
Since large amounts of valuable imaging data are continually being produced, ensuring that it is interoperable is highly important for future R&D. Imaging data is commonly used for research and oftentimes carries sensitive Protected Health Information (PHI) and Personal Identifiable Information (PII). As such, it falls under legal regulations such as the General Data Protection Regulation (GDPR) and the Health Insurance Portability and Accountability Act (HIPAA).
In the context of both regulatory and interoperability requirements, there needs to be a system. That system must be of a kind where secure retrieval and sharing of imaging data is possible. Tokenization fills this gap by substituting sensitive data with nonsensitive identifiers, or "tokens", protecting data while preserving its utility.
The need for tokenization and de-identification in medical imaging
Tokenization is used in databases or internal systems to replace sensitive data while keeping the actual data secure. But what exactly are tokens?
Tokens are values that are unrelated to each other, yet they preserve certain characteristics of the original data, typically length or format, ensuring continuity in business processes. The original sensitive data is stored securely outside of the organization’s internal systems.
Tokenized data is non-reversible and non-decipherable. There is no mathematical relationship between the token and the original data. This means the token cannot be reversed to reveal the original information unless additional information is provided.
Tokenization of Real-World Imaging Data (RWiD)
Imaging has now become a standard aspect of healthcare for diagnosing various diseases. It contributes to processes such as diagnosis, prognosis, therapy monitoring, and surveillance. And due to advancements in technology, acquiring, processing, and analyzing imaging datasets has become simpler. Without the analysis of RWiD, there will be limitations in the RWE and other types of studies. RWiD can assist in various stages of understanding diseases and drug development, whether used independently or combined with other dataset types (through tokenization).
RWiD aids in the discovery and examination of biomarkers while providing insights into the natural progression of diseases. During the trial phase, it can facilitate trial design and optimization, help with patient recruitment, and serve as an external control group. RWiD also enhances and generates more precise evidence following drug approvals.
Tokenization of RWiD is of greater importance than with respect to other categories of datasets, such as claims data. In contrast to typical datasets, RWiD often contains metadata that may contain PHI (Protected Health Information). Tokenizing such metadata is, thus, essential to maintain patient confidentiality and meet regulatory needs. Doing so makes it possible for organizations to exchange imaging data in a more efficient, secure, and compliant manner with various stakeholders. Also, tokenization facilitates interoperability, along with helping integrate different types of clinical data with imaging data.
How the process of tokenization works
Benefits of utilizing tokenized imaging data
Tokenized imaging data provides some important advantages in medicine, especially in the context of interoperability and privacy issues:
The Segmed advantage
Tokenization is an important process that transforms the landscape of radiology imaging data, ensuring its optimum utilization. The tokenization of imaging offers a better understanding of the patient journey as it enables its integration with other clinical data. This accelerates the research process and innovation, and drives advanced analytics enabled through artificial intelligence.
At Segmed, we provide fit-for-purpose, regulation-grade imaging datasets for pharmaceutical, medtech, and AI research and development.
Connect with us to find out how our high-quality, diverse, tokenized imaging datasets, when integrated with other tokenized datasets, can support a myriad of research and development for healthcare innovation.
Comments
Post a Comment